[1]邹　鹏,涂继军,陈治权,等.骨科患者创面感染肺炎克雷伯菌耐药性及毒力特性研究[J].新乡医学院学报,2021,38(6):534-539.[doi:10.7683/xxyxyxb.2021.06.008]
　ZOU Peng,TU Jijun,CHEN Zhiquan,et al.Resistance and virulence characteristics of Klebsiella pneumoniae isolated from patients with wounds infection in department of orthopedics[J].Journal of Xinxiang Medical University,2021,38(6):534-539.[doi:10.7683/xxyxyxb.2021.06.008]
点击复制

骨科患者创面感染肺炎克雷伯菌耐药性及毒力特性研究
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年6
页码:
534-539
栏目:
临床研究
出版日期:
2021-06-05

文章信息/Info

Title:
Resistance and virulence characteristics of Klebsiella pneumoniae isolated from patients with wounds infection in department of orthopedics
作者:
邹　鹏1; 涂继军2; 陈治权1; 杨永超1; 陈新锋1
（1.郑州市第七人民医院骨科，河南　郑州　450000；2.郑州市第七人民医院检验科，河南　郑州　450000）
Author(s):
ZOU Peng1; TU Jijun2; CHEN Zhiquan1; YANG Yongchao1; CHEN Xinfeng1
（1.Department of Orthopedics,the Seventh People′s Hospital of Zhengzhou,Zhengzhou 450000,Henan Province,China2.Department of Clinical Laboratory,the Seventh People′s Hospital of Zhengzhou,Zhengzhou 450000,Henan Province,China)
关键词:
肺炎克雷伯菌; 耐药性; 毒力表型; 毒力因子
Keywords:
Klebsiella pneumoniaedrug resistancevirulence phenotypevirulence factor
分类号:
R446.5
DOI:
10.7683/xxyxyxb.2021.06.008
文献标志码:
A
摘要:
目的　了解骨科患者创面感染肺炎克雷伯菌的耐药特性和毒力特性。方法　收集从2017年2月至2019年10月于郑州市第七人民医院骨科住院的创面感染患者的感染创面分离的肺炎克雷伯菌32株，应用肉汤稀释法测定肺炎克雷伯菌对13种常用抗菌药物的耐药性，荚膜染色和拉丝试验确定肺炎克雷伯菌的荚膜和黏液性毒力表型，结晶紫染色法测定肺炎克雷伯菌体外生物膜形成能力，聚合酶链反应法检测肺炎克雷伯菌的耐药基因和毒力基因。结果　32株肺炎克雷伯菌对13种抗菌药物的耐药率为6.25%～81.25%，其中对氨苄西林耐药率最高，为 81.25%；其次是头孢曲松和头孢哌酮，分别为75.00%和62.50%；对亚胺培南的耐药率最低，为6.25%。32株肺炎克雷伯菌均有荚膜，其中12株（37.50%）表现为高黏液性，21株（65.63%）形成生物膜。32株肺炎克雷伯菌携带的毒力基因主要为fimH-1［100.00% （32/32）］、entB［96.88%（31/32）］、markD［93.75%(30/32)］，21.88%(7/32)的菌株携带rmpA，18.75%(6/32)的菌株携带iroNB，magA基因的携带率最低［9.38%(3/32)］；携带的耐药基因主要为blaCTX-M、blaSHV、blaKPC、gyrA、qnrA，且表现为多药耐药。结论　骨科患者创面感染的肺炎克雷伯菌耐药较严重，其耐药性与毒力特性相关，高毒力菌株多表现为多重耐药。
Abstract:
Objective　To investigate the drug resistance and virulence characteristics of Klebsiella pneumoniae isolated from infected wounds of patients in department of orthopedics.Methods　　A total of 32 Klebsiella pneumoniae strains were collected from infected wounds of inpatients admitted to Department of Orthopedics,the Seventh People′s Hospital of Zhengzhou from February 2017 to October 2019.The drug resistance of Klebsiella pneumoniae against 13 antimicrobials commonly used in clinic were determined by the agar dilution method.The capacity of producing capsule and hypermucoviscosity of Klebsiella pneumoniae were determined by capsules staining and wire drawing test,respectively.The capacity of biofilm formation was determined by crystal violet staining assay.The polymerase chain reaction technology was used to detect the drug resistant gene and virulence gene.Results　The drug resistance rates of 32 Klebsiella pneumoniae against to 13 antimicrobials were 6.25%-81.25%.The drug resistance rate to ampicillin was the highest,which was 81.25%;the drug resistance rate to ceftriaxone and cefoperazone were 75.00% and 62.50%,respectively;the drug resistance rate to imipenem was the lowest,which was 6.25%.All of the 32 strains had capsule,12 strains(37.50%) could produce hypermucoviscosity and 21 strains (65.63%) could form biofilm.The main virulence factor genes were fimH-1［100.00%(32/32)］,entB［96.88%(31/32)］ and mrkD［93.75%(30/32)］,and followed by rmpA［21.88%(7/32)］ and iroNB［18.75%(6/32)］;the carrying rate of magA gene was the lowest,accounted for 9.38%(3/32).Most strains carried multiple drug-resistant genes,including blaCTX-M,blaSHV,blaKPC,gyrA,qnrA,and their showed multidrug resistance.Conclusion　The situation of drug resistance of Klebsiella pneumonia isolated from infected wounds of patients in department of orthopaedics is more serious,the drug resistance is related to the virulence factors,and the high-virulence strains mostly show multidrug resistance.

参考文献/References:

［1］　MARTIN R M,BACHMAN M A.Colonization,infection,and the accessory genome of Klebsiella pneumoniae［J］.Front Cell Infect Microbiol,2018,8:4.
［2］　CHOBY J E,HOWARD-ANDERSON J,WEISS D S.Hypervirulent Klebsiella pneumoniae-clinical and molecular perspectives［J］.J Intern Med,2020,287(3):283-300.
［3］　VASILYEV I Y,NIKOLAEVA I V,SINIAGINA M N,et al.Multidrug-resistant hypervirulent Klebsiella pneumoniae found persisting silently in infant gut microbiota［J］.Int J Microbiol,2020,2020:4054393.
［4］　WANG G,ZHAO G,CHAO X,et al.The characteristic of virulence,biofilm and antibiotic resistance of Klebsiella pneumoniae［J］.Int J Environ Res Public Health,2020,17(17):6278.
［5］　谢朝云,熊芸,蒙桂鸾,等.2011-2018年临床分离高黏液表型肺炎克雷伯菌临床分布与耐药率研究［J］.中华医院感染学杂志,2020,30(1):10-14.
［6］　MORADIGARAVAND D,MARTIN V,PEACOCK S J,et al.Evolution and epidemiology of multidrug-resistant Klebsiella pneumo-niae in the United Kingdom and Ireland［J］.mBio,2017,8(1):e01976-16.
［7］　CANEIRAS C,LITO L,MAYORALAS-ALISES S,et al.Virulence and resistance determinants of Klebsiella pneumoniae isolated from a Portuguese tertiary university hospital centre over a 31-year period［J］.Enferm Infect Microbiol Clin,2019,37(6):387-393.
［8］　EL FERTAS-AISSANI R,MESSAI Y,ALOUACHE S,et al.Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens［J］.Pathol Biol (Paris),2013,61(5):209-216.
［9］　Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing［M］.27th ed.CLSI supplement.M100.Wayne,PA:Clinical and Laboratory Standards Institute,2018:32-42
［10］　BREAKWELL D P,MOYES R B,REYNOLDS J.Differential staining of bacteria:capsule stain［J］.Curr Protoc Microbiol,2009,15(1):1-4.
［11］　SHON A S,BAJWA R P,RUSSO T A.Hypervirulent (hypermucoviscous) Klebsiella pneumoniae:a new and dangerous breed［J］.Virulence,2013,4(2):107-118.
［12］　SURGERS L,BOYD A,GIRARD P M,et al.Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae［J］.Int J Med Microbiol,2019,309(1):13-18.
［13］　ZHU K,JIN H,HE Z,et al.A continuous method for the large-scale extraction of plasmid DNA by modified boiling lysis［J］.Nat Protoc,2006,1(6):3088-3093.
［14］　田李均,王晓丽,肖淑珍,等.医院内高黏液性肺炎克雷伯菌的流行分布、毒力基因及临床特征分析［J］.上海交通大学学报(医学版),2017,37(1):43-48.
［15］　王学志,王金华,孙旭东,等.骨科患者医院感染病原学和耐药性分析［J］.中华医院感染学杂志,2019,29(14):2185-2188.
［16］　游明园,周小梅,廖小平,等.骨科住院患者医院感染多重耐药菌分布及耐药性分析［J］.中国消毒学杂志,2017,34(1):55-57.
［17］　张令博,袁英泽,何素瑞,等.某骨科医院2016-2017年临床分离病原菌流行病学与耐药特征分析［J］.中华医院感染学杂志,2018,28(22):115-118.
［18］　WILLSEY G G,VENTRONE S,SCHUTZ K C,et al.Pulmonary surfactant promotes virulence gene expression and biofilm formation in Klebsiella pneumoniae［J］.Infect Immun,2018,86(7):e00135-18.
［19］　WALKER K A,MiILLER V L.The intersection of capsule gene expression,hypermucoviscosity and hypervirulence in Klebsiella pneumoniae［J］.Curr Opin Microbiol,2020,54:95-102.
［20］　YANG F,DENG B,LIAO W,et al.High rate of multiresistant Klebsiella pneumoniae from human and animal origin［J］.Infect Drug Resis,2019,12:2729-2737
［21］　RAHDAR H A,MALEKABAD E S,DADASHI A R,et al.Correlation between biofilm formation and carbapenem resistance among clinical isolates of Klebsiella pneumoniae［J］.Ethiop J Health Sci,2019,29(6):745-750.
［22］　MOYA B,BARCELO I M,CABOT G,et al.In vitro and in vivo activities of β-lactams in combination with the novel β-lactam enhancers Zidebactam and WCK 5153 against multidrug-resistant metallo-β-lactamase-producing Klebsiella pneumoniae［J］.Antimicrob Agents Chemother,2019,63(5):e00128-19.
［23］　NATH S,MOUSSAVI F,ABRAHAM D,et al.In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae［J］.J Antimicrob Chemother,2018,73(2):431-436.
［24］　BASSETTI M,GIACOBBE D R,GIAMARELLOU H,et al.Ma-nagement of KPC-producing Klebsiella pneumoniae infections［J］.Clin Microbiol Infect,2018,24(2):133-144.
［25］　POIREL L,PITOUT J D,CALVO L,et al.In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase［J］.Antimicrob Agents Chemother,2006,50(4):1525-1527.
［26］　SZABO D,KOCISIS B,ROKUSZ L,et al.First detection of plasmid-mediated,quinolone resistance determinants qnrA,qnrB,qnrS and aac(6′)-Ib-cr in extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae in Budapest,Hungary［J］.J Antimicrob Chemother,2008,62(3):630-632.

相似文献/References:

[1]赵丽娟,汤丽霞,黄干荣,等.不同标本大肠埃希茵214株耐药性调查[J].新乡医学院学报,2002,19(04):271.
[2]王　娟,李　凯,王勇兵,等.革兰阴性菌血流感染患儿临床特点及病原菌分布和耐药性分析[J].新乡医学院学报,2019,36(7):634.[doi:10.7683/xxyxyxb.2019.07.008]
　WANG Juan,LI Kai,WANG Yong-bing,et al.Clinical characteristics,pathogenic bacteria distribution and drug resistance of children with gram-negative bacterial bloodstream infection[J].Journal of Xinxiang Medical University,2019,36(6):634.[doi:10.7683/xxyxyxb.2019.07.008]
[3]郭雄飞,王　挺,汤立新.脊柱手术后切口感染患者病原菌分布及耐药性和血清炎性因子水平分析[J].新乡医学院学报,2019,36(10):963.[doi:10.7683/xxyxyxb.2019.10.014]
　GUO Xiong-fei,WANG Ting,TANG Li-xin.Distribution of pathogenic bacteria and analysis of drug resistance and the levels of serum inflammatory factors in patients with incision infection after spinal operation[J].Journal of Xinxiang Medical University,2019,36(6):963.[doi:10.7683/xxyxyxb.2019.10.014]
[4]闫登科,陶　丽,郝　洁,等.内质网应激对肝癌细胞硼替佐米耐药性的影响[J].新乡医学院学报,2021,38(2):106.[doi:10.7683/xxyxyxb.2021.02.002]
　YAN Dengke,TAO Li,HAO Jie,et al.Effect of endoplasmic reticulum stress on the resistance of hepatocellular carcinoma cells to bortezomib[J].Journal of Xinxiang Medical University,2021,38(6):106.[doi:10.7683/xxyxyxb.2021.02.002]
[5]秦　 超,冯永海,杨闪闪,等.结肠癌转移相关基因1表达与肺鳞状细胞癌和肺腺癌细胞顺铂耐药性的相关性[J].新乡医学院学报,2021,38(3):249.[doi:10.7683/xxyxyxb.2021.03.009]
　QIN Chao,FENG Yonghai,YANG Shanshan,et al.Relationship between the expression of metastasis-associated in colon cancer 1 and cisplatin resistance in pulmonary squamous cell carcinoma and pulmonary adenocarcinoma cells[J].Journal of Xinxiang Medical University,2021,38(6):249.[doi:10.7683/xxyxyxb.2021.03.009]
[6]曹　彤,阳艳丽.急性淋巴细胞白血病患儿院内感染的病原菌分布及耐药性分析[J].新乡医学院学报,2020,37(2):173.[doi:10.7683/xxyxyxb.2020.02.017]
　CAO Tong,YANG Yanli.Distribution and drug resistance of pathogenic bacteria of nosocomial infection in children with acute lymphoblastic leukemia[J].Journal of Xinxiang Medical University,2020,37(6):173.[doi:10.7683/xxyxyxb.2020.02.017]
[7]韩　冬,张　超,杜守峰,等.冠状动脉旁路移植术后感染病原菌分布、耐药性及危险因素分析[J].新乡医学院学报,2020,37(8):773.[doi:10.7683/xxyxyxb.2020.08.017]
　HAN Dong,ZHANG Chao,DU Shoufeng,et al.Distribution characteristics and drug resistance of pathogenic bacteria and the risk factors of postoperative infection in patients underwent coronary artery bypass grafting[J].Journal of Xinxiang Medical University,2020,37(6):773.[doi:10.7683/xxyxyxb.2020.08.017]
[8]蒋子豪,赵永新,苏　兵,等.耐碳青霉烯类克雷伯菌耐药性分析[J].新乡医学院学报,2020,37(11):1057.[doi:10.7683/xxyxyxb.2020.11.012]
　JIANG Zihao,ZHAO Yongxin,SU Bing,et al.Drug resistance analysis of carbapenem resistant Klebsiella bacteria[J].Journal of Xinxiang Medical University,2020,37(6):1057.[doi:10.7683/xxyxyxb.2020.11.012]
[9]邢彦峰,巨超龙.结直肠癌患者术后感染的危险因素及病原菌和耐药性分析[J].新乡医学院学报,2018,35(2):110.[doi:10.7683/xxyxyxb.2018.02.007]
　XING Yan-feng,JU Chao-long.Analysis of the risk factors，pathogenic bacteria and drug resistance of postoperative infection in patients with colorectal cancer[J].Journal of Xinxiang Medical University,2018,35(6):110.[doi:10.7683/xxyxyxb.2018.02.007]
[10]郭新珍.侵袭性肺炎克雷伯菌肝脓肿综合征患者临床特征分析[J].新乡医学院学报,2018,35(6):525.[doi:10.7683/xxyxyxb.2018.06.019]
　GUO Xin-zhen.Analysis of the clinical features on invasive Klebsiella pneumoniae liver abscess syndrome[J].Journal of Xinxiang Medical University,2018,35(6):525.[doi:10.7683/xxyxyxb.2018.06.019]
[11]褚月娇,韩莹莹,黄婷婷,等.老年与中青年患者产超广谱β-内酰胺酶肺炎克雷伯菌的分布及耐药性对比分析[J].新乡医学院学报,2017,34(9):803.[doi:10.7683/xxyxyxb.2017.09.006]
　CHU Yue-jiao,HAN Ying-ying,HUANG Ting-ting,et al.Comparative analysis of distribution and drug resistance of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in elderly and young and middle-aged patients[J].Journal of Xinxiang Medical University,2017,34(6):803.[doi:10.7683/xxyxyxb.2017.09.006]

更新日期/Last Update: 2021-06-05